Morning News Recap: Atara Biotherapeutics Inc (NASDAQ:ATRA), Uranium Royalty Corp (NASDAQ:UROY)

ATRA has seen its SMA50 which is now 21.63%. In looking the SMA 200 we see that the stock has seen a -36.71%.

UROY has seen its SMA50 which is now -12.04%. In looking the SMA 200 we see that the stock has seen a 1.13%.

On 29-02-2024 (Thursday), Shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) encountered a difference of 9.41% after which it shut the day’ session at $0.83. The volume added 3,565,605 shares which compares with the average volume of 3.59M shares.

Atara Biotherapeutics Inc, a USA based Company, belongs to Biotechnology sector industry. Shares of Atara Biotherapeutics Inc was among the active stocks of the last exchanging sessions.


The stock value instability stayed at 18.18% in recent month and ranges at 12.18% for the week. The Average True Range (ATR) is also a measure of volatility is presently sitting at 0.11. The firm demonstrates the market capitalization of $107.50M.

Important Results:

Atara Biotherapeutics Inc has P/S value of 23.68 while its P/B esteem remains at 0. Likewise, the company has Return on Assets of 0.62%, Return on Equity of -425.97% and Return on Investment of 0.

The company demonstrates Gross Margin and Operating Margin of -390.18% and -6417.09% respectively.

Forward P/E of Atara Biotherapeutics Inc is remaining at 0. Forward P/E is a measure of the price-to-earnings ratio using forecasted earnings for the P/E calculation for the next fiscal year.

Technical Analysis of Atara Biotherapeutics Inc ATRA:

The stock price moved with change of 92.48% to its 50 Day low spot and changed -47.34% contrasting with its 50 Day high point. ATRA stock is as of now appearing down return of 5.72% all through a week ago and saw bearish return of 34.21% in one month span. The execution of company 36.28% in three months and -44.89% throughout the previous a half year exchanging period.

Tracking the closing price and 52-week high, the current price movement shows that the stock price positioned negative when compared against the 52-week high. As close of recent trade, stock represents -79.53%move from 52-week high. Tracing the 52-week low position of the stock, we noted that the closing price represents a 318.98% higher distance from that low value. Technical analysts compare a stock’s current trading price to its 52-week range to get a broad sense of how the stock is doing, as well as how much the stock’s price has fluctuated. This information may indicate the potential future range of the stock and how volatile the shares are.

Uranium Royalty Corp (NASDAQ:UROY)’s Analysis & Performances to Discover

Uranium Royalty Corp, belongs to Energy sector and Uranium industry. The company’s total Outstanding Shares of 99.80M. UROY flaunted 1.99% to reach at $2.60 during previous trading session.

The company has experienced volume of 684,200 shares while on average the company has a capacity of trading 1.71M share.

Observing the Technical Indicators:

Uranium Royalty Corp institutional ownership is held at 10.71% while insider ownership was 18.60%. As of now, UROY has a P/S, P/E and P/B values of 13.63, 366.30 and 1.73 respectively. Its P/Cash is valued at 5.10.

The Company’s net profit margin for the 12 months at 4.42%. Comparatively, the gazes have a Gross margin 22.99%.

Profitability ratios:

Looking into the profitability ratios of UROY stock, an investor will find its ROE, ROA, ROI standing at 0.65%, 0.62% and 0.56%, respectively.

Reading RSI Indicator

Uranium Royalty Corp (UROY) attained alert from day Traders as RSI reading reached at 37.47. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements.

Earnings per Share Details of Uranium Royalty Corp:

The EPS of UROY is strolling at 0.01, measuring its EPS growth this year at 149.81%. As a result, the company has an EPS growth of 0 for the approaching year.

What Does the Payout Ratio Tell You?

The payout ratio is a key financial metric used to determine the sustainability of a company’s dividend payments. It is the amount of dividends paid to shareholders relative to the total net income of a company.

Formula for the Payout Ratio Is

“Payout Ratio = Dividends / Earnings”

Is It Overvalued? Look at the Payout Ratio of ATRA, UROY

The payout ratio shows the proportion of earnings paid out as dividends to shareholders, typically expressed as a percentage of the company’s earnings. The payout ratio can also be expressed as dividends paid out as a proportion of cash flow. The payout ratio is also known as the dividend payout ratio. ATRA has a Payout Ratio of 0 and UROY has a Payout Ratio of 0.

Leave a Reply

Your email address will not be published. Required fields are marked *